The study revealed that younger patients (16-24 years) with moderate-to-severe psoriasis were more likely to discontinue TNF ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

Discover a recent study that has provided valuable insights into the experiences of Latine patients living with moderate to ...

Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...

If you’re looking for a shampoo that can relieve the flaking and itching associated with dandruff and is suitable for all ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $51.00 to $53.00 in a research note issued to investors on ...

Vitiligo is a condition that affects millions worldwide, yet it remains widely misunderstood. Characterised by white patches on the skin, it is an autoimmune di ...

A live Q&A session will follow the formal presentations. An audio recording of the presentation and Q&A will be available under the investor section of the FibroBiologics website after the event.

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink ...

The News took your common skincare concerns to the Yukon skincare experts for solutions that don't involve a trip down south ...